SAN FRANCISCO (EGMN) - Normalization of CA 125 levels after one cycle of chemotherapy is a significant predictor of recurrence-free and overall survival in women with high-risk, early-stage epithelial ovarian cancer, based on data from 350 patients."Identifying subsets of early-stage, high-risk patients with good prognosis may improve the individualization of care," said Dr. John Chan in a presentation of the Gynecologic Oncology Group (GOG) study results at the Society of Gynecologic Oncologists...